Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Pharma & metals drag down markets
Mon, 22 Sep 11:30 am

After opening weak, Indian Indices have remained well below the dotted line in the morning session. Stocks from the pharma and metal sectors are leading the losses while auto and consumer durables stocks are trading in the green.

The BSE-Sensex is trading down 92 points. The NSE-Nifty is trading down 38 points. However, the midcap and small cap stocks are in favour today. The BSE Mid Cap index is trading up 0.2% and the BSE Small Cap index is trading up 0.5%. The rupee is trading at 60.74 to the US dollar.

Most software stocks are trading lower today. Infosys and Wipro are leading the losers. As per a leading financial daily, India's fifth largest software firm Tech Mahindra, has reiterated its FY17 revenue target of US$ 5 bn. Executive vice-chairman Vineet Nayyar has stated that the growth outlook is positive and the company will continue to pursue M&A opportunities. He also clarified that the company views inorganic growth opportunities strategically and not as a means of growing revenues. The company reported revenues just a little over US$ 3 bn in FY14. Tech Mahindra has pursued an aggressive growth path since 2009 when it acquired the erstwhile Satyam Computers. Tech Mahindra is currently trading flat.

Indian pharma stocks are trading mixed today, with Cipla and Aurobindo pharma being among the leading losers in the pack while Dishman and Panacea biotech are among the leading gainers. As per the financial daily, the USFDA will start the inspection at Aurobindo Pharma's drugs manufacturing facilities. Reportedly, during the 1QFY15 conference call the management indicated that the audits of unit III, unit IV, and unit VII are due for inspection. The US authorities will soon start audit of unit IV in next few days. The total sales from this unit are US$ 50 m per annum. This unit manufactures various injectables and drugs targeting ophthalmology segment. Last inspection of this plant was done in 2012. While these inspections are routine by nature, however it is important for the companies to follow good manufacturing practices (GMP) in order to avoid negative observations.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Pharma & metals drag down markets". Click here!


Views on News

Why Rising Bond Yields Spooked the Market (Fast Profits Daily)

Mar 2, 2021

The stock market has been worried about rising bond yields recently and for good reason. In this video, I'll tell you why.

Bond Yields Are Surging. What Should Be Your Debt Funds Strategy (Outside View)

Mar 2, 2021

Bond Yields are surging. PersonalFN explains the outlook for Debt Markets and what should be your debt funds strategy in a rising interest rate scenario.

Such China Challenger Stocks are STILL Ignored and Undervalued (Profit Hunter)

Mar 2, 2021

Don't mistake defence stocks to be the only China challengers.

Beware the Ides of March (Fast Profits Daily)

Mar 1, 2021

The month of March is usually difficult for traders. This time it will be even more so. Find out why in this video.

UTI Nifty200 Momentum 30 Index Fund: Aims to Benefit from Momentum Investing Strategy (Outside View)

Mar 1, 2021

PersonalFN analyses the features of UTI Nifty200 Momentum 30 Index Fund and explains the potential this fund has to offer to its investors.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Mar 2, 2021 (Close)